Morgan Stanley analyst Jeffrey Hung downgraded CervoMed (NASDAQ: CRVO) from Equalweight to Underweight.The analyst comments: "As we outlined previously, CervoMed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE